Millions of retirees treat the annual switch between Medicare Advantage and Original Medicare as routine housekeeping, but the move can quietly strip away one of the program’s most valuable protections. Dropping a private Advantage plan to return to Original Medicare often reopens the door to medical underwriting on a Medigap supplement, meaning an insurer can weigh a person’s full health history before agreeing to sell a policy. For a beneficiary who has developed a serious condition since first signing up, that single decision can turn an affordable supplement into an expensive one, or shut it off entirely.
Where the guaranteed-issue protection actually applies
A Medigap policy fills the gaps Original Medicare leaves behind, covering much of the coinsurance, copayments and deductibles that would otherwise land directly on the beneficiary. The catch is that the strongest buying protections exist only for a limited stretch of time. During the six-month Medigap open enrollment period that begins once someone is 65 or older and enrolled in Part B, an insurer cannot use medical answers to deny a policy or raise its price. Outside that one-time window, the rules shift sharply against a new applicant.
After open enrollment closes, companies are generally free to require medical underwriting, and they can refuse an applicant or charge more based on existing conditions unless the person qualifies for a narrow set of protections. Those situations, known as guaranteed issue rights, force an insurer to sell certain policies regardless of health and to cover pre-existing conditions without a waiting period. The trouble for switchers is that simply walking away from a Medicare Advantage plan does not automatically hand a beneficiary one of those protections.
The distinction is easy to miss because the two systems feel interchangeable during the annual enrollment season, when marketing pitches present switching as a low-stakes choice. In practice, the protections attached to a supplement operate on their own separate timetable, one tied to age, first enrollment and a short list of qualifying events rather than to the open enrollment calendar that governs Advantage and drug plans. A beneficiary who treats all of these deadlines as a single decision can lose a right without ever realizing it existed.
Free retirement updates: Social Security and Medicare change every year, and nobody sends you a memo. Our free Retirement Shield newsletter breaks down what changed and what to do. Get it free in your inbox.
The trial-right window most switchers miss
Federal rules do carve out a protected path, but it is far narrower than many assume. A so-called trial right applies to someone who joined a Medicare Advantage plan when first eligible for Medicare and then decides, within the first 12 months, to return to Original Medicare. That person keeps the right to buy a supplement without a health screening. A parallel trial right covers a beneficiary who dropped a Medigap policy to try Advantage for the first time and then switches back within a year, provided the earlier policy is still sold in the market.
Beyond those first-year trial periods, the guaranteed protection largely disappears. A retiree who spent several years in an Advantage plan and later wants to move to Original Medicare with a supplement is, in most states, subject to the insurer’s medical review. Medicare’s guidance on how to switch or drop a Medigap policy warns that timing determines whether an application can be turned down at all. A handful of states impose broader year-round or annual buying rights, but those remain the exception rather than the national rule.
State variation makes the picture even harder to read from a distance. A rule that guarantees a supplement in one state may have no equivalent across the border, so two retirees in identical health can face completely different odds of buying coverage after leaving Advantage. Because those state protections change and rarely make headlines, a beneficiary planning a switch has to confirm the current rules where they actually live rather than relying on what a neighbor or a national brochure describes.
Why the timing gamble carries real financial weight
The stakes are highest for the beneficiaries who most need supplemental coverage. Someone in good health may clear underwriting and secure a policy at a competitive rate, but a person managing cancer, heart disease or another costly diagnosis could face a flat denial or a premium that makes the supplement impractical. That leaves the retiree exposed to Original Medicare’s open-ended coinsurance, which carries no annual limit on out-of-pocket spending the way most Advantage plans do, precisely when medical bills are mounting.
The decision also runs in one direction more easily than the other. Enrolling in a Medicare Advantage plan rarely involves any health screening, so the door into Advantage tends to stay open in later years. The door back to Original Medicare with a guaranteed supplement can quietly lock behind a beneficiary who waits past the trial window. That asymmetry is worth weighing before a first Advantage enrollment, because a choice made at 65 can shape the cost of every switch that follows across the rest of retirement.
For anyone considering a move this fall, the sharper question is not only which plan looks better on paper but whether a supplement will still be available and affordable if the return trip ever becomes necessary. That lingering uncertainty, rather than the monthly premium, is often the more consequential part of leaving Advantage behind, and it is the part least likely to appear in a glossy plan brochure or a fast-talking sales call.
This article was researched and drafted with the assistance of artificial intelligence.
More Financial Reading
